CCL3L1 dose and HIV-1 susceptibility

Trends in Molecular Medicine

Volumn 11, Issue 5, 2005, Pages 203-206

  Mackay, Charles R ^a  

^a GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CHEMOKINE; CHEMOKINE CCL3L1; CHEMOKINE RECEPTOR; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIVIRAL ACTIVITY; CYTOTOXICITY; DISEASE COURSE; DISEASE PREDISPOSITION; ETHNOLOGY; GENE EXPRESSION; GENE MUTATION; GENOTYPE; HEREDITY; HOST RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; NONHUMAN; REVIEW;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 18844449658     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmed.2005.03.003     Document Type: Short Survey

References (14)

1. M. Dean Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia growth and development study, multicenter AIDS cohort study, multicenter hemophilia cohort study, San Francisco city cohort, ALIVE Study Science 273 1996 1856 1862
2. S.J. O'Brien, and G.W. Nelson Human genes that limit AIDS Nat. Genet. 36 2004 565 574
3. D. Nolan Impact of host genetics on HIV disease progression and treatment: new conflicts on an ancient battleground AIDS 18 2004 1231 1240
4. E. Gonzalez The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility Science 307 2005 1434 1440
5. P. Menten Macrophage inflammatory protein-1 Cytokine Growth Factor Rev. 13 2002 455 481
6. J.R. Townson Gene copy number regulates the production of the human chemokine CCL3-L1 Eur. J. Immunol. 32 2002 3016 3026
7. M.J. Bugeja Analysis of the CCL3-L1 gene for association with HIV-1 susceptibility and disease progression AIDS 18 2004 1069 1071
8. F. Sallusto Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses Immunol. Today 19 1998 568 574
9. B. Combadiere The chemokine receptor CX3CR1 controls homing and anti-viral potencies of CD8 effector-memory T lymphocytes in HIV-infected patients AIDS 17 2003 1279 1290
10. J.C. Stephens Dating the origin of the CCR5-Δ32 AIDS-resistance allele by the coalescence of haplotypes Am. J. Hum. Genet. 62 1998 1507 1515
11. A.P. Galvani, and M. Slatkin Evaluating plague and smallpox as historical selective pressures for the CCR5-Δ32 HIV-resistance allele Proc. Natl. Acad. Sci. U. S. A. 100 2003 15276 15279
12. J.M. Farber, and E.A. Berger HIV's response to a CCR5 inhibitor: I'd rather tighten than switch! Proc. Natl. Acad. Sci. U. S. A. 99 2002 1749 1751
13. F. Shaheen, and R.G. Collman Co-receptor antagonists as HIV-1 entry inhibitors Curr. Opin. Infect. Dis. 17 2004 7 16
14. M.M. Lederman Prevention of vaginal SHIV transmission in rhesus macaques through inhibition of CCR5 Science 306 2004 485 487